Navigating Cancer, a Seattle startup that makes software to help providers and patients manage cancer treatment, landed $26 million in a Series D investment round. The funding was led by… Read More
Story updated with comments from Scholz below. Seattle biotech startup OncoSenX has reeled in $3 million to advance its pipeline of therapeutics that aim to kill cancer cells based on… Read More
Seattle-based startup Navigating Cancer has raised $12 million for its digital platform that lets cancer doctors interact with their patients. The round drew investments from existing investors including Merck Global… Read More
Good Therapeutics, a new Seattle biotech startup that aims to develop protein drugs that act only when needed, raised $11 million in an equity round, according to a new SEC… Read More
Researchers at the Fred Hutchinson Cancer Research Center led by Dr. Cyrus Ghajar recently uncovered promising new science in the battle against metastatic breast cancer. Their findings, published today in… Read More
Adaptive Biotechnologies has signed a $300 million collaborative licensing agreement with Genentech to develop highly personalized cancer therapies. In addition to the up-front payment, Adaptive could receive up to $2… Read More
Navigating Cancer has hired longtime technology executive Bill Bunker as CEO to help the Seattle-based company “realize the vision” for its oncology patient management software platform. Bunker takes over for… Read More